Calif. biotech startup gets $20M funding boost

05/30/2013 | MedCityNews.com

Kite Pharma, a California-based biotech focused on developing novel cancer immunotherapies, secured $20 million in its latest funding round. Kite has access to the National Cancer Institute's pipeline of engineered autologous peripheral blood T cells that can be targeted to multiple hematological and solid tumor types.

View Full Article in:

MedCityNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA